CL vs CPIX · P/E 34, rev $20.38B vs rev $10.4M
Colgate-Palmolive Company (CL) versus Cumberland Pharmaceuticals Inc (CPIX) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CPIX currently screens at market cap $86.9M.
Not investment advice. Open the CL and CPIX stock pages for the full models.
Not investment advice.